Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | BDX Becton Dickinson | ABT Abbott Laboratories |
|---|---|---|
| Price | $180.94 -0.2% | $102.61 +0.4% |
| StockIQ Score | 55C Moderate Risk: High | 51C- Moderate Risk: Medium |
| Technical | 61C+ | 19F |
| Fundamental | 55C | 72B |
| Growth | 34F | 45D+ |
| Fair Value | 38F | 38F |
| News | 100A+ | 100A+ |
| Quality | 58C | 63C+ |
| Risk | 42D | 54C- |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Becton Dickinson (BDX) has a slightly stronger technical score (57 vs. 50) and a more balanced fundamental score (55 vs. 72), while Abbott Laboratories (ABT) leads in growth (45 vs. 34) and fundamental strength. Both share identical investor and valuation scores (38), but ABT’s higher growth score makes it stand out in expansion potential.